Covered recipient · General Payments record
LINDSAY R LITTLEHALES
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2022–2024
$635.87
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $275.78 | 22 |
| Education | $188.00 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $194.93 | 3 |
| ABBVIE INC. | $154.27 | 17 |
| Lundbeck LLC | $68.87 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $29.37 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $16.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.33 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104890235 | CMS |
| ABBVIE INC. | $11.08 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104890237 | CMS |
| ABBVIE INC. | $11.08 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104890239 | CMS |
| ABBVIE INC. | $5.72 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104890241 | CMS |
| ABBVIE INC. | $9.73 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104890243 | CMS |
| ABBVIE INC. | $8.88 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104890245 | CMS |
| ABBVIE INC. | $16.00 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104890247 | CMS |
| ABBVIE INC. | $8.38 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104890249 | CMS |
| ABBVIE INC. | $8.38 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104890251 | CMS |
| ABBVIE INC. | $0.76 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104890253 | CMS |
| ABBVIE INC. | $6.58 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104890255 | CMS |
| ABBVIE INC. | $6.58 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104890257 | CMS |
| ABBVIE INC. | $7.43 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104890259 | CMS |
| ABBVIE INC. | $15.93 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104890261 | CMS |
| ABBVIE INC. | $10.71 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104890263 | CMS |
| ABBVIE INC. | $6.68 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104890265 | CMS |
| ABBVIE INC. | $11.02 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104890267 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $16.34 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144451995 | CMS |
| Lundbeck LLC | $15.44 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145940084 | CMS |
| Lundbeck LLC | $53.43 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145940086 | CMS |
| Novartis Pharmaceuticals Corporation | $29.37 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087145954 | CMS |
| Teva Pharmaceuticals USA, Inc. | $6.93 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151587628 | CMS |
| Teva Pharmaceuticals USA, Inc. | $89.00 | 08/21/2024 | Education | Undisputed | 01/23/2026 | 1151587640 | CMS |
| Teva Pharmaceuticals USA, Inc. | $99.00 | 08/21/2024 | Education | Undisputed | 01/23/2026 | 1151587642 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.